| Literature DB >> 32676283 |
Cihan Kaya1, Ismail Alay1, Sukru Yildiz1, Huseyin Cengiz1, Xalide Afandi1, Levent Yasar1.
Abstract
OBJECTIVES: Natural orifice transluminal endoscopic surgery (NOTES) has been performed in gynecology practice for the surgical treatment of ovarian cysts, uterine fibroids, ectopic pregnancies, adnexal masses, and pelvic organ prolapse. The aim of this study is to evaluate the intraoperative and postoperative outcomes of patients who underwent NOTES for gynecological diseases.Entities:
Keywords: Gynecology; hysterectomy; laparoscopy; natural orifice transluminal endoscopic surgery; salpingectomy
Year: 2020 PMID: 32676283 PMCID: PMC7354749 DOI: 10.4103/GMIT.GMIT_84_19
Source DB: PubMed Journal: Gynecol Minim Invasive Ther ISSN: 2213-3070
Figure 1The figure demonstrates gynecological procedures performed via natural orifice transluminal endoscopic surgery technic. (a) A right tubal ectopic pregnancy. (b) A left adnexectomy procedure. (c) Total vaginal natural orifice transluminal endoscopic surgery hysterectomy procedure. (d) Natural orifice transluminal endoscopic surgery-assisted myomectomy procedure
Patients’ basic characteristics and surgical outcomes of hysterectomy±bilateral salpingo-oophorectomy and adnexectomy cases
| Mean±SD (range) | ||
|---|---|---|
| Hysterectomy +/− BSO ( | Adnexectomy ( | |
| Age (years) | 51.75±8.06 (41-72) | 43.76±11.01 (19-66) |
| Gravidity | 3.07±1.76 (1-9) | 3.64±2.08 (2-9) |
| Parity | 2.78±1.34 (1-7) | 2.61±1.62 (0-7) |
| BMI (kg/m2) | 31.71±8.35 (22-54) | 32.74±9.91 (20-54) |
| Dimension of the mass (mm) | ||
| Uterine fibroid | 65.31±14.54 (41-93) | N/A |
| Adnexal mass | N/A | 70.29±19.07 (40-120) |
| Ectopic pregnancy | N/A | 31.25±5.96 (27-40) |
| Number of previous abdominal surgery | 0±0.83 (0-3) | 0±1.05 (0-3) |
| Preoperative Hb (g/dL) | 11.28±1.99 (8-15) | 12±1.76 (9-15) |
| Preoperative Hct (%) | 33.5±4.05 (27-42) | 35.11±3.35 (30-41) |
| Decrease of Hb | 1.28±1.11 (1-4) | 1.66±0.79 (1-4) |
| Decrease of Hct | 2.42±2.64 (3-6) | 3.19±2.31 (2-8) |
| Colpotomy time (min) | 13.61±9.11 (4-45) | 5.84±2.77 (2-15) |
| Duration of surgery (min) | 85.25±34.31 (40-170) | 53.15±34.61 (25-120) |
| Uterine weight (g) | 298.07±208.42 (102-786) | N/A |
| Uterine size (week) | 10.14±2.11 (8-16) | N/A |
| Postoperative Hb (g/dL) | 10±1.74 (7-13) | 10.47±1.58 (8-13) |
| Postoperative Hct (%) | 31.01±2.77 (27-36) | 32.23±3.36 (26-38) |
| Duration of hospital stay (days) | 2.07±0.89 (1-4) | 1.63±0.68 (1-3) |
| Blood loss (cc) | 90.45±106.03 (25-500) | 60.88±34.11 (20-150) |
| Postoperative 6th hour VAS score | 6±0.5 (4-8) | 5±1.45 (3-8) |
| Postoperative 24th hour VAS score | 2±1.28 (2-4) | 2±0.51 (0-3) |
BSO: Bilateral salpingo-oophorectomy, BMI: Body mass index, Hb: Hemoglobin, Hct: Hematocrit, VAS: Visual analog scale, N/A: Not available
Type and indications of previous and present abdominal surgeries and final pathology results of hysterectomy±bilateral salpingo-oophorectomy and adnexectomy cases
| Hysterectomy +/− BSO, | Adnexectomy, | |
|---|---|---|
| Type of previous incision | ||
| Pfannenstiel | 6 (66.4) | 4 (58) |
| McBurney | 1 (11.1) | 0 |
| Umbilical | 1 (11.1) | 1 (14) |
| Midline | 0 | 1 (14) |
| Subcostal | 1 (11.1) | 1 (14) |
| Indication of previous surgery | ||
| Cesarean section | 6 (66.4) | 4 (58) |
| Appendectomy | 1 (11.1) | 0 |
| Cholecystectomy | 1 (11.1) | 1 (14) |
| Umbilical hernia | 1 (11.1) | 1 (14) |
| Pelvic mass | 0 | 1 (14) |
| Indication of present surgery | ||
| HMB | 23 (82.1) | 0 |
| Pelvic mass | 2 (7.2) | 17 (81) |
| Ectopic pregnancy | 0 | 4 (19) |
| Pelvic pain | 3 (10.7) | 0 |
| Final pathology | ||
| Dermoid cyst | 1 (3.6) | 8 (38) |
| Simple serous cyst | 0 | 6 (30) |
| Ectopic pregnancy | 0 | 4 (19) |
| Endometrioma | 0 | 1 (4) |
| Fibrothecoma | 0 | 2 (9) |
| Uterine fibroid | 14 (50) | 0 |
| Adenomyosis | 8 (28.6) | 0 |
| Endometrial hyperplasia | 5 (17.9) | 0 |
BSO: Bilateral salpingo-oophorectomy, HMB: Heavy menstrual bleeding